Instem announced that Guangdong Lewwin Pharmaceutical Research Institute Co. Ltd. has purchased the Provantis preclinical software solution suite to manage preclinical processes at the Center for Drug Non-clinical Evaluation and Research of Guangdong Institute of Applied Biological Resources in Guangdong, Southern China. Provantis will replace existing manual processes at the Guangdong facility, delivering increased efficiencies in the collection, storage and reporting of preclinical data, as well as ensuring GLP and regulatory compliance. Guangdong Lewwin Pharmaceutical to deploy an extensive suite of modules including General Toxicology, Reproductive Toxicology, Pathology, Protocol Report & Assembly, Clinical Pathology, Tables & Statistics, Dispense and Data Import. Contract awarded following a rigorous competitive evaluation; Provantis recognized as the global market leader and the overwhelming standard within China. Evaluation included extended onsite visits to two existing Instem clients within China. Client to harness the power of the Instem University e-learning platform and a range of professional services to facilitate quick implementation and a rapid return on investment. Instem’s Provantis solution was the first western toxicology/pathology software to enter into the Chinese market, deploying its initial system in one of the larger and most advanced vivariums during 2006. As the Chinese preclinical market continues to grow, Instem is leading the market, with its Provantis solution deployed at more sites within the region than any competing product. Instem has an established full-service office in Shanghai and supports organizations through traditional on-site systems, as well as through its SaaS delivery model from a secure, professionally managed data center based in Shanghai.